Liaoning Chengda Biotechnology Co.,Ltd. (SHA:688739)
China · Delayed Price · Currency is CNY 27.59
-0.31 (-1.11%)
Last updated: Jul 16, 2025
SHA:688739 Market Cap
SHA:688739 has a market cap or net worth of 11.40 billion as of July 16, 2025. Its market cap has increased by 6.47% in one year.
Market Cap
11.40B
Enterprise Value
6.01B
Revenue
1.67B
Ranking
n/a
PE Ratio
34.16
Stock Price
27.59
Market Cap Chart
Since October 28, 2021, SHA:688739's market cap has decreased from 33.32B to 11.40B, a decrease of -65.79%. That is a compound annual growth rate of -25.06%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 16, 2025 | 11.40B | 7.41% |
| Dec 31, 2024 | 10.61B | -21.62% |
| Dec 29, 2023 | 13.54B | 6.87% |
| Dec 30, 2022 | 12.67B | -60.04% |
| Dec 31, 2021 | 31.70B | -4.84% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Jiangsu Hengrui Medicine | 382.38B |
| Shenzhen Mindray Bio-Medical Electronics | 262.44B |
| WuXi AppTec | 228.64B |
| Zhangzhou Pientzehuang Pharmaceutical., | 119.33B |
| Aier Eye Hospital Group | 114.99B |
| Sichuan Biokin Pharmaceutical | 113.84B |
| Shanghai United Imaging Healthcare | 102.37B |
| Yunnan Baiyao Group Co.,Ltd | 99.90B |